HomeENZN • OTCMKTS
add
Enzon Pharmaceuticals Inc
Previous close
$0.14
Day range
$0.13 - $0.14
Year range
$0.060 - $0.24
Market cap
9.86M USD
Avg Volume
22.54K
P/E ratio
31.42
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 26.00K | — |
Operating expense | 351.00K | 10.38% |
Net income | 276.00K | 50.82% |
Net profit margin | 1.06K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 1.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.23M | 0.21% |
Total assets | 46.99M | 0.69% |
Total liabilities | 410.00K | 1.99% |
Total equity | 46.58M | — |
Shares outstanding | 74.21M | — |
Price to book | 3.50 | — |
Return on assets | -1.73% | — |
Return on capital | -1.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 276.00K | 50.82% |
Cash from operations | 241.00K | -5.12% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | 241.00K | -5.12% |
Free cash flow | -242.12K | -35.45% |
About
Enzon Pharmaceuticals, Inc. is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties. Wikipedia
Founded
1981
Headquarters
Website
